ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

26,970Medicare Part D Prescriptions Filled, Including Refills

Rank: 21 out of 2343

$1.69M Total Retail Price of All Prescriptions

Rank: 14 out of 2343

401 Patients Receiving at Least One Drug in Part D
87%Patients 65 Years and Older
95% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Pennsylvania
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

9% of this provider’s 401 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

1% of this provider’s 24,534 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

38% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$63 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

67 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Pennsylvania
SIMVASTATIN 1,133 985 1 1
CREON 767 679 2 197
METFORMIN HCL 706 596 3 9
METOPROLOL TARTRATE 685 615 4 7
CLONIDINE HCL 670 635 5 70
AMLODIPINE BESYLATE 652 613 6 5
ATENOLOL 622 555 7 12
OMEPRAZOLE 597 546 8 4
LISINOPRIL 575 474 9 3
LOVAZA 551 512 10 113
CARVEDILOL 526 503 11 27
LEVOTHYROXINE SODIUM 478 444 12 2
DIOVAN 452 445 13 23
FUROSEMIDE 441 412 14 6
MECLIZINE HCL 432 421 15 103
NAMENDA 388 388 16 36
GABAPENTIN 380 324 17 16
ALENDRONATE SODIUM 341 341 18 28
ISOSORBIDE MONONITRATE ER 293 293 19 32
NEXIUM 290 283 20 33
SYNTHROID 285 274 21 40
WARFARIN SODIUM 281 265 22 8
CLOPIDOGREL 275 255 23 26
ESCITALOPRAM OXALATE 275 269 23 55
DIOVAN HCT 272 269 25 63
PLAVIX 269 259 26 38
TAMSULOSIN HCL 264 259 27 29
IBUPROFEN 257 241 28 75
ATORVASTATIN CALCIUM 236 235 29 10
JANUVIA 235 188 30 50
LOSARTAN POTASSIUM 214 181 31 19
POTASSIUM CHLORIDE 210 197 32 18
FLUTICASONE PROPIONATE 207 183 33 46
PAROXETINE HCL 204 192 34 66
FAMOTIDINE 203 184 35 60
LIDODERM 189 179 36 130
SERTRALINE HCL 185 167 37 20
RANITIDINE HCL 182 152 38 43
LIPITOR 180 176 39 78
DONEPEZIL HCL 179 179 40 21
ZOLPIDEM TARTRATE 178 167 41 24
METFORMIN HCL ER 173 161 42 88
NITROSTAT 173 173 42 164
SINGULAIR 171 154 44 100
GLYBURIDE 162 141 R 45 62
PROCTOZONE-HC 153 136 46 208
HYDROCHLOROTHIAZIDE 150 143 47 11
PRANDIN 148 130 48 140
ADVAIR DISKUS 148 127 48 34
AMMONIUM LACTATE 148 146 48 228
KLOR-CON 10 147 147 51 134
NAPROXEN 140 107 52 108
ALCOHOL PREP PADS 138 134 53 284
CHLORHEXIDINE GLUCONATE 134 129 54 219
PREDNISONE 134 119 54 37
LEXAPRO 131 131 56 178
AZITHROMYCIN 131 111 56 39
NIASPAN 125 124 58 141
LOSARTAN-HYDROCHLOROTHIAZIDE 123 115 59 64
ROPINIROLE HCL 120 120 60 124
AMLODIPINE BESYLATE-BENAZEPRIL 119 119 61 59
CYMBALTA 119 85 61 74
TRIAMCINOLONE ACETONIDE 115 100 63 137
SINGLE USE SWAB 113 96 64 241
DEXILANT 112 94 65 184
PROAIR HFA 112 110 65 86
SOLARAZE 108 106 67 277
ASMANEX 107 105 68 422
LISINOPRIL-HYDROCHLOROTHIAZIDE 102 77 69 42
VOLTAREN 101 75 70 175
ALLOPURINOL 100 90 71 31
MONTELUKAST SODIUM 96 87 72 181
METOLAZONE 93 93 73 173
TRAMADOL HCL 92 79 74 25
CLOTRIMAZOLE-BETAMETHASONE 92 86 74 127
FINASTERIDE 91 83 76 80
ZETIA 90 80 77 52
METOPROLOL SUCCINATE 86 86 78 14
POLYETHYLENE GLYCOL 3350 83 78 79 54
ONGLYZA 80 79 80 211
PANTOPRAZOLE SODIUM 78 78 81 22
PRAVASTATIN SODIUM 78 72 81 15
MISOPROSTOL 78 72 81 431
DICLOFENAC SODIUM 78 67 81 155
INSULIN SYRINGE 76 42 85 102
SOTALOL 76 76 85 177
PRIMIDONE 74 74 87 318
PEN NEEDLE 74 49 87 119
CELEBREX 74 74 87 71
ZENPEP 73 73 90 353
DILTIAZEM 24HR CD 73 73 90 83
KETOCONAZOLE 71 66 92 232
NIFEDIPINE ER 70 70 93 89
NATEGLINIDE 69 59 94 255
CRESTOR 69 69 94 30
MIRTAZAPINE 68 40 96 41
LIDOCAINE 68 56 96 258
GLIMEPIRIDE 67 67 98 45
HYDRALAZINE HCL 66 66 99 92
BENAZEPRIL HCL 65 65 100 113
LANSOPRAZOLE 65 53 100 162
NASONEX 65 58 100 209
BUSPIRONE HCL 65 60 100 146
LOVASTATIN 64 48 104 47
DICYCLOMINE HCL 64 63 104 202
PREMARIN 61 51 R 106 286
LACTULOSE 59 52 107 139
HYDROCODONE-ACETAMINOPHEN 59 43 S3 107 13
ACARBOSE 58 58 109 334
KLOR-CON M10 58 48 109 107
ENALAPRIL MALEATE 57 57 111 58
LEVOCETIRIZINE DIHYDROCHLORIDE 57 47 111 223
CYCLOBENZAPRINE HCL 57 36 R 111 109
SURE COMFORT ALCOHOL 57 46 111 415
COLCRYS 56 46 115 166
PROMETHAZINE HCL 56 48 R 115 222
TRICOR 56 37 115 96
NITROGLYCERIN PATCH 55 44 118 147
LEVOFLOXACIN 54 49 119 106
VYTORIN 54 54 119 185
ALCOHOL SWABS 51 51 121 303
GEMFIBROZIL 50 25 122 133
SUCRALFATE 50 48 122 248
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 20, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.